The annual cost of blood transfusions in the UK

Transfusion Medicine

Volumn 13, Issue 4, 2003, Pages 205-218

  Varney, S J ^a   Guest, Julian F ^a  

^a CATALYST Health Economics Consultants   (United Kingdom)

Author keywords

Blood; Costs; Economics; Resource use; Transfusions; UK

Indexed keywords

FRESH FROZEN PLASMA;

APHERESIS; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CRYOPRECIPITATION; ERYTHROCYTE TRANSFUSION; HEALTH CARE COST; HEALTH ECONOMICS; HEALTH SERVICE; HUMAN; LYMPHOCYTE DEPLETION; THROMBOCYTE TRANSFUSION; UNITED KINGDOM;

ABSENTEEISM; ADOLESCENT; ADULT; AGED; BLOOD BANKS; BLOOD COMPONENT REMOVAL; BLOOD COMPONENT TRANSFUSION; BLOOD DONORS; BLOOD TRANSFUSION; CHILD; CHILD CARE; FEMALE; FORECASTING; GREAT BRITAIN; HEALTH CARE COSTS; HEALTH EXPENDITURES; HOSPITAL COSTS; HUMANS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; TRAVEL;

EID: 0042697567     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3148.2003.00443.x     Document Type: Article

References (41)

1. Barrett-Lee, P.J., Bailey, N.P. & Wager, E. (2000) Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy. British Journal of Cancer, 82 (1), 93-97.
2. Blumberg, N., Kirkley, S.A. & Heal, J.M. (1996) A cost analysis of autologous and allogeneic transfusions in hip replacement surgery. American Journal of Surgery, 171, 324-330.
3. Carless, P.A., Anthony, D.M. & Henry, D.A. (2002) Systematic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusion. The British Journal of Surgery, 89 (6), 695-703.
4. Cavill, I. (2002) Reducing blood transfusion. Focus should be on improving patients' ability to make own blood. BMJ, 325 (7365), 655.
5. Crawford, J., Cella, D., Cleeland, C.S., Cremieux, P.Y., Demetri, G.D., Sarokhan, B.J., Slavin, M.B. & Glaspy, J.A. (2002) Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer, 95 (4), 888-895.
6. Department of Health (2001a) Hospital Episode Statistics. Department of Health, London (available from: http://www.doh.gov.uk/hes).
7. Department of Health (2001b) NHS Reference Costs. Department of Health, London.
8. Guest, J.F., Munro, V. & Cookson, R.F. (1998) The annual cost of blood transfusions in the United Kingdom. Clinical and Laboratory Haematology, 20, 111-118.
9. Haynes, S.L., Torella, F., Wong, J.C., Dalrymple, K., James, M. & McCollum, C.N. (2002) Economic evaluation of a randomised clinical trial of haemodilution with cell salvage in aortic surgery. The British Journal of Surgery, 89 (6), 731-736.
10. Health and Personal Social Services (2001) Hospital Statistics. Regional Information Branch, Belfast.
11. Health Solutions Wales (2001) Patient Episode Database for Wales (PEDW). Velindre NHS Trust, Cardiff.
12. Healy, J.C., Frankforter, S.A., Graves, B.K., Reddy, R.L. & Beck, J.R. (1994) Preoperative autologous blood donation in total hip arthroplasty - a cost effectiveness analysis. Archives of Pathology & Laboratory Medicine, 118, 465-470.
13. Hill, S.R., Carless, P.A., Henry, D.A., Carson, J.L., Hebert, P.C., McClelland, D.B. & Henderson, K.M. (2002) Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews, (2), CD002042.
14. Inland Revenue (2002) PA YE and NICS Rates and Limits for 2002-2003. The Inland Revenue, London.
15. van Hulst, M., de Wolf, J.T., Staginnus, U., Ruitenberg, E.J. & Postma, M.J. (2002) Pharmaco-economics of blood transfusion safety: review of the available evidence. Vox Sanguinis, 83 (2), 146-155.
16. Information and Statistics Division (2001) Scottish Morbidity Register (SMRO1). Scottish Executive, Edinburgh.
17. John Hutton, M.P. Hansard Commons Deb, 3 December 2001, 376, c121w.
18. Joint Professional Advisory Committee (2001) Donor Selection Guidelines (8th edn) (available from: http://www.transfusionguidelines.org.uk/donors_index.html).
19. Lind, M., Vernon, C., Cruickshank, D., Wilkinson, P., Littlewood, T., Stuart, N., Jenkinson, C., Grey-Amante, P., Doll, H. & Wild, D. (2002) The level of haemoglobin in anaemic cancer patients correlates positively with quality of life. British Journal of Cancer, 86 (8), 1243-1249.
20. Littlewood, T. (2001) Erythropoietin for the treatment of anemia associated with haematological malignancy. Hematological Oncology, 19 (1), 19-30.
21. McClelland, D.B.L. (ed.) (2001) Handbook of Transfusion Medicine (3rd edn). The Stationery Office, London.
22. Monthly Index of Medical Specialities. Haymarket Medical Publications Ltd, London.
23. National Audit Office (2000) The National Blood Service. Report by the Comptroller and Auditor General HC 6 Session 2000-2001. National Audit Office, London.
24. National Blood Authority (2001) Annual Accounts of the National Blood Authority 2000-2001. National Blood Authority, Watford.
25. National Blood Service (2001) Annual Report 2000-2001. National Blood Service, Watford.
26. Netten, A. & Curtis, C. (2000) Unit Costs of Health and Social Care 2000. PSSRU University of Kent, Canterbury.
27. NHS England and Wales (2000) Drug Tariff. The Stationery Office, London.
28. NHS Executive (1998a) Government Accepts Advice on Leucodepletion from Spongiform Encephalopathy Advisory Committee. Department of Health, London (Department of Health Press Release: 1998/295).
29. NHS Executive (1998b) Better Blood Transfusion. Department of Health, London (Health Service Circular (HSC): 1998/224).
30. NHS Executive (2002) Better Blood Transfusion: Appropriate Use of Blood. Department of Health, London (Health Service Circular (HSC): 2002/009).
31. Northern Ireland Blood Transfusion Service (2001) Annual Report 2000-2001. Northern Ireland Blood Transfusion Service, Belfast.
32. Northern Ireland Blood Transfusion Service (Special Agency) (2001) Statement of Accounts Year Ended 31st March 2001. Northern Ireland Blood Transfusion Service (Special Agency), Belfast.
33. Regan, F. & Taylor, C. (2002) Recent developments: blood transfusion medicine. BMJ, 325, 143-147.
34. Remak, E., Hutton, J. & Zagari, M. (2002) Changes in cost-effectiveness over time: the case of epoetin alfa for renal replacement therapy patients in the UK. ISPOR 5th Annual European Conference, 3-5 November, Rotterdam, Netherlands [Abstracts]. Value Health, 5 (6), 458.
35. Reynolds, E., Wickenden, C. & Oliver, A. (2001) The impact of improved safety on maintaining a sufficient blood supply. Transfusion Clinique et Biologique, 8 (3), 235-239.
36. Scottish National Blood Transfusion Service (2000) Annual Report 1999-2000. Scottish National Blood Transfusion Service, Edinburgh.
37. Serious Hazards of Transfusion Committee (2002) SHOT Annual Report 2000-2001. SHOT, Manchester.
38. Torella, F., Haynes, S.L., Lardi, A., O'Dwyer, S.T. & McCollum, C.N. (2001) Unchanging attitudes to autologous transfusion in the UK. Transfusion Medicine, 11, 15-19.
39. Velindre NHS Trust (2001) Annual Accounts (2000-2001). Velindre NHS Trust, Cardiff.
40. Wells, A.W., Mounter, P.J., Chapman, C.E., Stainsby, D. & Wallis, J.P. (2002) Where does blood go? Prospective observational study of red cell transfusion in north England. BMJ, 325, 803.
41. Welsh Blood Service (2001) Annual Report 2000-2001. Welsh Blood Service, Cardiff.